BRAINSTORM CELL THERAPEUTICS INC. Earnings Per Share (Basic)
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Earnings Per Share (Basic) of -$0.35 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- BRAINSTORM CELL THERAPEUTICS INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.35.
- BRAINSTORM CELL THERAPEUTICS INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.19.
- BRAINSTORM CELL THERAPEUTICS INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.22.
- BRAINSTORM CELL THERAPEUTICS INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.19.
- BRAINSTORM CELL THERAPEUTICS INC. earnings per share, basic for fiscal 2025 was -$1.11.
- BRAINSTORM CELL THERAPEUTICS INC. earnings per share, basic for fiscal 2024 was -$2.31.
- BRAINSTORM CELL THERAPEUTICS INC. earnings per share, basic for fiscal 2023 was -$6.00.
- BRAINSTORM CELL THERAPEUTICS INC. earnings per share, basic for fiscal 2022 was -$0.66.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.35 10-Q · filed 2026-08-14 | -$0.54 10-Q · filed 2026-08-14 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$0.19 10-Q · filed 2026-05-15 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.11 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$0.19 10-Q · filed 2025-11-14 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.91 10-Q · filed 2025-11-14 | -$1.37 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$0.34 10-Q · filed 2026-08-14 | -$0.77 10-Q · filed 2026-08-14 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.76 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-03-31 | -$0.45 10-Q · filed 2026-05-15 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.01 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2024-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.31 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$0.51 10-Q · filed 2025-11-14 | -$1.04 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$1.80 10-Q · filed 2025-11-14 | -$3.20 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||||
| 2024-06-30 | -$0.60 10-Q · filed 2025-08-14 | -$0.04 10-Q · filed 2024-08-14 | -$1.35 10-Q · filed 2025-08-14 | -$0.09 10-Q · filed 2024-08-14 | -$2.76 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$3.30 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||
| 2024-03-31 | -$0.75 10-Q · filed 2025-05-15 | -$0.05 10-Q · filed 2024-05-14 | -$2.32 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$2.86 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$1.23 derived: net income ÷ weighted average shares · filed 2025-11-14 | |||
| 2023-12-31 | -$1.62 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$2.13 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.79 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$6.00 10-K · filed 2025-03-31 | -$0.40 10-K · filed 2024-04-01 | |||
| 2023-09-30 | -$0.45 10-Q · filed 2024-11-14 | -$0.03 10-Q · filed 2023-11-14 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$4.35 10-Q · filed 2024-11-14 | -$0.29 10-Q · filed 2023-11-14 | -$0.57 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-06-30 | -$0.13 10-Q · filed 2024-08-14 | -$0.27 10-Q · filed 2024-08-14 | -$0.41 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.60 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-03-31 | -$0.14 10-Q · filed 2024-05-14 | -$0.27 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.46 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.66 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2022-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$0.32 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$0.66 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$0.19 10-Q · filed 2023-11-14 | -$0.38 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.53 10-Q · filed 2023-11-14 | -$0.70 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||||
| 2022-06-30 | -$0.19 10-Q · filed 2023-08-14 | -$0.34 10-Q · filed 2023-08-14 | -$0.51 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.66 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||||
| 2022-03-31 | -$0.15 10-Q · filed 2023-05-15 | -$0.32 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.46 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.64 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||||
| 2021-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.32 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.49 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.68 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$0.15 10-Q · filed 2022-11-14 | -$0.32 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.51 10-Q · filed 2022-11-14 | -$0.85 derived: net income ÷ weighted average shares · filed 2022-11-14 | ||||
| 2021-06-30 | -$0.17 10-Q · filed 2022-08-15 | -$0.36 10-Q · filed 2022-08-15 | -$0.70 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-11-14 | ||||
| 2021-03-31 | -$0.19 10-Q · filed 2022-05-16 | -$0.53 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.69 derived: net income ÷ weighted average shares · filed 2022-11-14 | |||||
| 2020-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2022-03-28 | -$0.51 derived: net income ÷ weighted average shares · filed 2022-03-28 | -$1.07 10-K · filed 2022-03-28 | |||||
| 2020-09-30 | -$0.14 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.70 derived: net income ÷ weighted average shares · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |